Sort
15,842 grants matching “pancreatic cancer”
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
$456,831Thomas Edward Wales · Northeastern University · R01 · FY2024 · CA
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$456,813Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$456,813Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
Cancer under pressure: Mechanisms of adaptation to compressive stress
$456,688Liam J Holt · New York University School Of Medicine · R37 · FY2023 · CA
CANCER RISK DETECTION BY MUTATIONAL LOAD DISTRIBUTION AN
$456,615Yale University · U01 · FY2001 · CA
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
$456,286Xiao-Fan Wang · Duke University · R01 · FY2020 · CA
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance
$456,227Aimee L Edinger · University Of California-Irvine · R01 · FY2024 · CA
MEASUREMENT ERRORS IN CANCER EPIDEMIOLOGY
$456,222Brigham And Women'S Hospital · R01 · FY2000 · CA
Bioactive small molecule development- PKM2 program
$455,928Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Branched chain amino acids and pancreatic cancer
$455,856Kathryn Elaine Wellen · University Of Pennsylvania · R01 · FY2023 · CA
Branched chain amino acids and pancreatic cancer
$455,856Kathryn Elaine Wellen · University Of Pennsylvania · R01 · FY2022 · CA
Defining epigenetic signaling to reshape pancreatic tumor microenvironment
$455,853Jiaqi Shi · University Of Michigan At Ann Arbor · R37 · FY2023 · CA
University of Minnesota Clinical Center for the Study of Pancreatic Disease
$455,667Melena D. Bellin · University Of Minnesota · U01 · FY2022 · DK
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS
$455,662Christopher E Forsmark · University Of Florida · U01 · FY2021 · DK
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS
$455,662Christopher E Forsmark · University Of Florida · U01 · FY2022 · DK
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS
$455,662Christopher E Forsmark · University Of Florida · U01 · FY2023 · DK
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS
$455,662Christopher E Forsmark · University Of Florida · U01 · FY2020 · DK
Neurogenic Amplification of Pancreatitis Pain
$455,585Karin N Westlund-High · University Of Kentucky · R01 · FY2011 · NS
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
$455,443Sapna Syngal · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
$455,443Sapna Syngal · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
$455,443Sapna Syngal · Dana-Farber Cancer Inst · R01 · FY2018 · CA
A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL
$455,331Emanuele Cocucci · Ohio State University · R01 · FY2025 · CA
Molecular Beacons and Activatable Probes for Cancer Detection and Analysis
$455,230Gang Bao · Emory University · U54 · FY2009 · CA
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA
$454,817Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2018 · CA
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA
$454,817Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2017 · CA